Session Details
[O20]Complex Disorders and Bioinfomatics (English Session)
Fri. Nov 20, 2026 3:30 PM - 4:30 PM JST
Fri. Nov 20, 2026 6:30 AM - 7:30 AM UTC
Fri. Nov 20, 2026 6:30 AM - 7:30 AM UTC
Room 6 (Meeting Room 3, Exhibition Building, Sendai International Center)
Chair: Kazuyoshi Hosomichi (Tokyo University of Pharmacy and Life Sciences), Jun Ohashi (Graduate School of Science, The University of Tokyo)
[English Session]
[O20-01]Expression and chromatin accessibility QTL of 29 FACS-sorted immune cells reveal mechanisms of immune-mediated disease
Hiroki Kitaoka1,2, Rintaro Fujimoto1,2,3, Saya Hisano2,3, Akiko Oguchi2,4, Raku Son2,4, Ryuya Edahiro2,3, Go Sato1,2, Yoshihiko Tomofuji1,2, Matteo Guerrini2, Yasuhiro Murakawa2,4, Akari Suzuki2, Yukinori Okada1,2,3, Kazuhiko Yamamoto2 (1. Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2. RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 3. Graduate School of Medicine, The University of Osaka, Suita, Japan, 4. Graduate School of Medicine, Kyoto University, Kyoto, Japan)
[O20-02]Shared and ASD-preferential whole-genome risk layers in autism and schizophrenia
Itaru Kushima1,2, Ran Wei3, Ikuko Natsukari4, Hidekazu Kato1, Hiroki Kimura1, Yoshihiro Nawa1, Youta Torii1, Maeri Yamamoto1, Yu Hayashi1, Daisuke Mori5, Yuko Arioka6, Hiroki Okumura7, Sawako Furukawa1, Junya Matsumoto8, Yuka Yasuda9, Satsuki Ito8, Yuichiro Watanabe10, Ryo Morikawa10, Satoko Takano10, Jun Egawa10 (1. Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2. Medical Genomics Center, Nagoya University Hospital, Nagoya, Japan, 3. National Institute of Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan, 4. Department of Psychiatry, Yakitsubeno-Michi Clinic, Yaizu, Japan, 5. Brain and Mind Research Center, Nagoya University, Nagoya, Japan, 6. Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan, 7. Department of Hospital Pharmacy, Nagoya University Hospital, Nagoya, Japan, 8. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan, 9. LifeGrowBrilliant Mental Clinic, Medical Corporation Foster, Osaka, Japan, 10. Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan)
[O20-03]Comprehensive analysis of Japanese-specific multiple-nucleotide variants and their potential regulatory effects
Chinatsu Yasuda1,2, Yuya Tahara-Arai1,2, Haruka Ozaki1,2 (1. Bioinformatics Laboratory, Institute of Medicine, University of Tsukuba, Iba raki, Japan, 2. RIKEN Center for Biosystems Dynamics Research, Laboratory for AI Biology)
[O20-04]Cross-ancestry transferability of mitochondrial DNA copy number-associated variants in a Japanese population
Gohar Rahman1, Takehiro Sato2, Hiromasa Tsujiguchi3, Takayuki Kannon4, Kazuyoshi Hosomichi5, Risa L. Iwasaki1, Sadahiro Iwabuchi1, Akinori Hara3, Hiroyuki Nakamura3, Atsushi Tajima1 (1. Department of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Ishikawa, Japan, 2. Department of Human Biology and Anatomy, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan, 3. Department of Hygiene and Public Health, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan, 4. Division of Computational Science, International Center for Brain Science, Fujita Health University, Aichi, Japan, 5. Laboratory of Computational Genomics, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan)
[O20-05]Trans-ethnic meta-analysis reveals the contribution of HLA-A*31:01 to susceptibility to carbamazepine-induced SJS/TEN
Koya Fukunaga1, Kim Hajung3, Maiko Kurata4, Yoshiko Mizukawa4, Hiroyuki Niihara5, Eishin Morita5, Yuko Watanabe6, Yukie Yamaguchi6, Hideaki Watanabe7, Saeko Nakajima8, Takashi Nomura8, Kenji Kabashima8, Mikiko Tohyama9, Hiroaki Azukizawa10, Hideo Asada10, Akito Hasegawa11, Natsumi Hama11, Takeshi Ozeki1, Kayoko Matsunaga12, Eri Tsukagoshi2 (1. Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 2. Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan, 3. College of Pharmacy, Seoul National University, Seoul, Republic of Korea, 4. Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan, 5. Department of Dermatology, Faculty of Medicine, Shimane University, Shimane, Japan, 6. Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 7. Department of Dermatology, Showa Medical University Northern Yokohama Hospital, Yokohama, Japan, 8. Department of Dermatology, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan, 9. Department of Dermatology, National Hospital Organization Shikoku Cancer Center, Japan, 10. Department of Dermatology, School of Medicine, Nara Medical University, Kashihara, Japan, 11. Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 12. Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan)
[O20-06]Detection and analysis of complex genome structural variation in postmortem brains of donors with psychiatric disorders
Bo Zhou1, Joseph Arthur2, Hanmin Guo2, Taeyoung Kim3, Yiling Huang2, Soumya Kundu2, Tao Wang2, Annika Weimer4, John Fullard5, Jaroslav Bendel5, Kiran Girdhar5, Giltae Song3, Dean Palejev6, Heinrich Zu Dohna7, Panos Roussos5, Anshul Kundaje2, Joachim Hallmayer2, Michael Snyder2, Wing Wong2, Alexander Urban2 (1. Texas A&M University, USA, 2. Stanford University, USA, 3. Pusan National University, South Korea, 4. Broad Institute of MIT and Harvard, USA, 5. Icahn School of Medicine at Mount Sinai, USA, 6. Bulgarian Academy of Sciences, Bulgaria, 7. American University of Dubai, U.A.E.)
